Q3 2025 · 13F-HR
HSG Holding Ltdholdings as filed
Filed 2025-11-14 · accession 0001193125-25-282908
$1.92B
Reported value
19
Positions
2025-09-30
Period end
The Brief · HSG Holding Ltd · Q3 2025
AI · grounded in 13F
HSG Holding Ltd established a new position in PDD valued at $1.48B. The fund also initiated new stakes in FUTU for $125.3M and BULL for $106.4M. Additional new positions include BZ, COE, and BEKE. Total assets under management stand at $1.92B across 19 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 722304102 | PDD | PDD HOLDINGS INC | $1.48B | 77.2% | 11,348,426 | Common | SOLE |
| 36118L106 | FUTU | FUTU HLDGS LTD | $125.3M | 6.52% | 740,352 | Common | SOLE |
| G9572D103 | BULL | WEBULL CORP | $106.4M | 5.54% | 9,553,639 | Common | SOLE |
| 48553T106 | BZ | KANZHUN LIMITED | $41.8M | 2.17% | 1,900,000 | Common | SOLE |
| 16954L204 | COE | 51TALK ONLINE EDUCATION GROU | $36.6M | 1.90% | 667,223 | Common | SOLE |
| 482497104 | BEKE | KE HLDGS INC | $35.7M | 1.86% | 1,939,017 | Common | SOLE |
| 732908108 | PONY | PONY AI INC | $20.7M | 1.08% | 1,076,905 | Common | SOLE |
| 25445D101 | DDL | DINGDONG CAYMAN LTD | $20.5M | 1.07% | 11,141,166 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $13.0M | 0.68% | 663,308 | Common | SOLE |
| 54572F101 | LOT | LOTUS TECHNOLOGY INC | $9.1M | 0.47% | 4,834,099 | Common | SOLE |
| G8656L130 | THCH | TH INTERNATIONAL LIMITED | $7.0M | 0.37% | 2,900,606 | Common | SOLE |
| G11448100 | BTDR | BITDEER TECHNOLOGIES GROUP | $7.0M | 0.36% | 293,732 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.6M | 0.24% | 266,062 | Common | SOLE |
| 65487X102 | NOAH | NOAH HLDGS LTD | $4.5M | 0.23% | 396,815 | Common | SOLE |
| 005329107 | ADAG | ADAGENE INC | $2.5M | 0.13% | 1,343,364 | Common | SOLE |
| 91864C107 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $2.0M | 0.10% | 1,420,473 | Common | SOLE |
| 055474209 | SLAI | BIT MINING LIMITED | $855,042 | 0.04% | 350,427 | Common | SOLE |
| 12233L206 | BNR | BURNING ROCK BIOTECH LTD | $215,302 | 0.01% | 21,212 | Common | SOLE |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $73,104 | 0.00% | 152,299 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.